BUSINESS
Alembic Pharmaceuticals moves up on getting USFDA’s nod for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals is currently trading at Rs. 873.20, up by 5.75 points or 0.66% from its previous closing of Rs. 867.45 on the BSE. The scrip opened at…